Literature DB >> 24583756

Yield of screening colonoscopy in first-degree relatives of patients with serrated polyposis syndrome.

Yark Hazewinkel1, Jan-Jacob Koornstra, Karam S Boparai, Theo A M van Os, Kristien M A J Tytgat, Susanne Van Eeden, Paul Fockens, Evelien Dekker.   

Abstract

GOALS: We aimed to evaluate the diagnostic yield of screening colonoscopies in first-degree relatives (FDRs) of patients with serrated polyposis syndrome (SPS).
BACKGROUND: Patients with SPS are at an increased risk for colorectal cancer. Although inheritance patterns are unknown, FDRs of these patients have an increased risk for both colorectal cancer and SPS. Prospective studies evaluating the yield of screening colonoscopies in this group are however scarce. This information would be useful to evaluate a possible mode of inheritance and to investigate whether screening colonoscopies are justified in this group. STUDY: FDR of patients with SPS were invited to undergo colonoscopy. The diagnostic yield was expressed by the number of FDRs with at least 1 significant polyp relative to the total number of included FDRs. Significant polyps were defined adenomas, traditional serrated adenomas, sessile serrated adenoma/polyp, or proximal hyperplastic polyp. Tissue specimens were reviewed by one expert pathologist.
RESULTS: Seventy-seven FDRs underwent colonoscopy (median age 52 y; interquartile range, 41 to 60). Colorectal cancer was not diagnosed. One or more significant polyps were detected in 43% of FDRs. No differences based on age, gender, or familial relationship were observed in the detection of polyps. Seven first-degree (9%) relatives had multiple polyps (≥5). Eleven (14%) FDRs fulfilled SPS WHO-criterion 2, of whom 1 sibling also met SPS WHO-criterion 3.
CONCLUSIONS: The yield of a single screening colonoscopy in FDRs of patients with serrated polyposis is substantial, warranting a colonoscopy screening program for these individuals.

Entities:  

Mesh:

Year:  2015        PMID: 24583756     DOI: 10.1097/MCG.0000000000000103

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  8 in total

Review 1.  Serrated Polyps of Colon and Rectum: a Clinicopathologic Review.

Authors:  Bita Geramizadeh; Scott Robertson
Journal:  J Gastrointest Cancer       Date:  2017-12

2.  Serrated polyposis: the problem of definition and its relationship to the population at risk for syndrome-related colorectal cancer.

Authors:  Joanne P Young; Timothy J Price; Susan Parry
Journal:  Transl Cancer Res       Date:  2017-12       Impact factor: 1.241

3.  The (ir)relevance of the abandoned criterion II for the diagnosis of serrated polyposis syndrome: a retrospective cohort study.

Authors:  Arne G C Bleijenberg; Joep E G IJspeert; Daniel Rodríguez-Alcalde; Sabela Carballal; Maurits R Visser; Maria Pellise; Jan Jacob Koornstra; Salman A Rana; Andrew Latchford; Francesc Balaguer; Evelien Dekker
Journal:  Fam Cancer       Date:  2020-04       Impact factor: 2.375

Review 4.  Hereditary or Not? Understanding Serrated Polyposis Syndrome.

Authors:  Peter P Stanich; Rachel Pearlman
Journal:  Curr Treat Options Gastroenterol       Date:  2019-12

5.  Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG).

Authors:  Kevin J Monahan; Nicola Bradshaw; Sunil Dolwani; Bianca Desouza; Malcolm G Dunlop; James E East; Mohammad Ilyas; Asha Kaur; Fiona Lalloo; Andrew Latchford; Matthew D Rutter; Ian Tomlinson; Huw J W Thomas; James Hill
Journal:  Gut       Date:  2019-11-28       Impact factor: 23.059

6.  Clinicopathological Characteristics of Serrated Polyposis Syndrome in Korea: Single Center Experience.

Authors:  Hyung-Keun Kim; Kyung-Jin Seo; Hyun Ho Choi; Sung Soo Kim; Hiun-Suk Chae; Ok-Ran Shin; Chang Hyuck Ahn; Young-Seok Cho
Journal:  Gastroenterol Res Pract       Date:  2015-05-12       Impact factor: 2.260

7.  Serrated polyposis associated with a family history of colorectal cancer and/or polyps: The preferential location of polyps in the colon and rectum defines two molecular entities.

Authors:  Patrícia Silva; Cristina Albuquerque; Pedro Lage; Vanessa Fontes; Ricardo Fonseca; Inês Vitoriano; Bruno Filipe; Paula Rodrigues; Susana Moita; Sara Ferreira; Rita Sousa; Isabel Claro; Carlos Nobre Leitão; Paula Chaves; António Dias Pereira
Journal:  Int J Mol Med       Date:  2016-07-05       Impact factor: 4.101

8.  Clinical predictors for sessile serrated polyposis syndrome: A case control study.

Authors:  Yang Wu; Alexander Mullin; Alina Stoita
Journal:  World J Gastrointest Endosc       Date:  2017-09-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.